Results 151 to 160 of about 7,620,317 (286)

Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini   +28 more
wiley   +1 more source

International Health Law: International, Regional, and National Perspectives

open access: yesGroningen Journal of International Law, 2015
As a developing field in its own right, the area of international health law itself reflects the ethos of GroJIL, striving to provide innovative insights into contemporary challenges facing international law.
Groningen Journal of International Law
doaj  

Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli   +5 more
wiley   +1 more source

Earned settlement: the value of international health and care workers in the UK. [PDF]

open access: yesLancet Reg Health Eur
Zhou X   +6 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Correction: Leaving no one behind on the road to Universal Health Coverage: The Kerala story

open access: yesInternational Journal for Equity in Health
International Journal for Equity in Health
doaj   +1 more source

Challenges in international health financing and implications for the new pandemic fund. [PDF]

open access: yesGlobal Health, 2023
Brown GW   +5 more
europepmc   +1 more source

International Health

open access: yesAmerican Journal of Public Health and the Nations Health, 1929
openaire   +3 more sources

Inclusion of Persons with Disabilities in the Health Financing System in Tanzania [PDF]

open access: yes, 2013
German Agency for International Cooperation, (GIZ) Tanzania   +1 more
core  

Home - About - Disclaimer - Privacy